Asia Pacific NASH Biomarker market

japan accounted for the largest market share in 2018 in the asia pacific nash biomarker market, and is expected to reach usd 83.00 million in 2024 from usd 26.80 million in 2018. however, india is the fastest growing market, which is expected to grow at a cagr of 22.32% during the forecast period 2019 - 2024. pharmaceutical companies and cros segment accounted for the largest market share in 2018, this market is expected to reach usd 93.40 million in 2024 from usd 29.40 million in 2018. this market is projected to grow at a cagr of 19.77% during the forecast period from 2019 - 2024. serum biomarkers segment accounted for the largest market share in 2018, this market is expected to reach usd 90.80 million in 2024 from usd 28.40 million in 2018. this market is projected to grow at a cagr of 19.73% during the forecast period from 2019 - 2024. however, hepatic fibrosis biomarkers segment is the fastest growing market, which is expected to grow at a cagr of 19.89% during the forecast period 2019 - 2024.